These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2869226)
1. HTLV-III antibodies in patients with kidney transplants or on haemodialysis. Neumayer HH; Wagner K; Kresse S Lancet; 1986 Mar; 1(8479):497. PubMed ID: 2869226 [No Abstract] [Full Text] [Related]
2. Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Goldman M; Liesnard C; Vanherweghem JL; Dolle N; Toussaint C; Sprecher S; Cogniaux J; Thiry L Br Med J (Clin Res Ed); 1986 Jul; 293(6540):161-2. PubMed ID: 3089438 [TBL] [Abstract][Full Text] [Related]
3. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation]. Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545 [TBL] [Abstract][Full Text] [Related]
4. [Anti-LAV/HTLV III antibodies in patients under hemodialysis receiving blood transfusion protocols. A retrospective study of 2 transplant centers]. Ferec C; Deroff P; Bourbigot B; Herve JP; Le Guy P; Bignon JD; Boudard D; Soulillou JP Presse Med; 1986 Sep; 15(29):1378. PubMed ID: 2950422 [No Abstract] [Full Text] [Related]
5. Screening haemodialysis patients for infection with human immune deficiency virus (HIV). De Santo NG; Tarro G; Giordano C; Capodicasa G; Esposito C; Flaminio G; Sodano G; Caropreso MR; Pluvio M; Giordano D J Infect; 1987 May; 14(3):229-32. PubMed ID: 3035028 [TBL] [Abstract][Full Text] [Related]
6. Investigation of human T-lymphotropic virus III serology in a renal transplant population. Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Dawson G; Falk L; Gutierrez R; Hollinger JB; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 3):2172-5. PubMed ID: 3547918 [No Abstract] [Full Text] [Related]
7. [Anti-HTLV-III antibodies. Methods of detection and biological significance]. Ercilla MG; Barrera JM Med Clin (Barc); 1986 Jan; 86(3):123-5. PubMed ID: 3457227 [No Abstract] [Full Text] [Related]
8. HIV infection in patients on dialysis and after renal transplantation. Heering P; Heinzler P; Bach D; Srampical B; Scheid A; Grabensee B Clin Nephrol; 1987 Apr; 27(4):212-3. PubMed ID: 3555910 [No Abstract] [Full Text] [Related]
9. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis? Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568 [No Abstract] [Full Text] [Related]
10. An analysis of serum samples positive for HTLV-III antibodies. Petricciani JC; Seto B; Wells M; Quinnan G; McDougal JS; Bodner AJ N Engl J Med; 1985 Jul; 313(1):47-8. PubMed ID: 2582255 [No Abstract] [Full Text] [Related]
11. Risk of HIV infection in recipients of blood and blood products. Uberti Foppa C; Zanchetta N; Nardi G; Re T; Orlando G; Cinque P; Lazzarin A Chemioterapia; 1987 Jun; 6(2 Suppl):633-4. PubMed ID: 3334654 [No Abstract] [Full Text] [Related]
12. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Kumar P; Pearson JE; Martin DH; Leech SH; Buisseret PD; Bezbak HC; Gonzalez FM; Royer JR; Streicher HZ; Saxinger WC Ann Intern Med; 1987 Feb; 106(2):244-5. PubMed ID: 3541725 [No Abstract] [Full Text] [Related]
13. Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Baillod RA; Lui SF; Sweny P; Ross MG; Griffiths PD; Grundy J; Moorhead JF Br Med J (Clin Res Ed); 1986 Sep; 293(6550):819. PubMed ID: 3094672 [No Abstract] [Full Text] [Related]
14. [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]. Flepp M; Täuber MG; Lüthy R; Frauchiger B; Barandun J; Schütze M; Joller H; Frey-Wettstein M; Vetter W; Siegenthaler W Schweiz Med Wochenschr; 1986 Apr; 116(14):426-8. PubMed ID: 3008323 [TBL] [Abstract][Full Text] [Related]
15. Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients. Feduska NJ; Perkins HA; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Garovoy M; Salvatierra O Transplant Proc; 1987 Feb; 19(1 Pt 3):2161-6. PubMed ID: 3547917 [No Abstract] [Full Text] [Related]
16. Interpretation of tests for the HTLV-III and hepatitis viruses. Vellend H Trans Assoc Life Insur Med Dir Am; 1987; 70():177-87. PubMed ID: 3474821 [No Abstract] [Full Text] [Related]
17. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria. Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480 [TBL] [Abstract][Full Text] [Related]
18. Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Ulstrup JC; Skaug K; Figenschau KJ; Orstavik I; Bruun JN; Petersen G Lancet; 1986 May; 1(8490):1151-2. PubMed ID: 2871400 [No Abstract] [Full Text] [Related]
19. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)]. Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290 [No Abstract] [Full Text] [Related]
20. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients]. Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123 [No Abstract] [Full Text] [Related] [Next] [New Search]